Oral platelet glycoprotein IIb/IIIa receptor antagonists: The present challenge is safety

被引：0
作者：
Vorchheimer, DA [1 ]
Fuster, V [1 ]
机构：
[1] Mt Sinai Med Ctr, Cardiovasc Inst, New York, NY 10029 USA
来源：
CIRCULATION | 1998年 / 97卷 / 04期
关键词：
editorials; glycoproteins; platelets; platelet aggregation inhibitors; drugs;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 26 条
[11]   Management of restenosis after coronary intervention [J].
Dangas, G ;
Fuster, V .
AMERICAN HEART JOURNAL, 1996, 132 (02) :428-436
[12]   PREVALENCE OF TOTAL CORONARY-OCCLUSION DURING THE EARLY HOURS OF TRANSMURAL MYOCARDIAL-INFARCTION [J].
DEWOOD, MA ;
SPORES, J ;
NOTSKE, R ;
MOUSER, LT ;
BURROUGHS, R ;
GOLDEN, MS ;
LANG, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (16) :897-902
[13]   CORONARY PLAQUE DISRUPTION [J].
FALK, E ;
SHAH, PK ;
FUSTER, V .
CIRCULATION, 1995, 92 (03) :657-671
[14]  
Hanrath P, 1997, CIRCULATION, V96, P1445
[15]   Design and methodology of the PURSUIT trial: Evaluating eptifibatide for acute ischemic coronary syndromes [J].
Harrington, RA .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (4A) :B34-B38
[16]   Differential dose-response to oral xemilofiban after antecedent intravenous abciximab - Administration for complex coronary intervention [J].
Kereiakes, DJ ;
Runyon, JP ;
Kleiman, NS ;
Higby, NA ;
Anderson, LC ;
Hantsbarger, G ;
McDonald, S ;
Anders, RJ .
CIRCULATION, 1996, 94 (05) :906-910
[17]   MECHANISMS OF DISEASE - PLATELET GLYCOPROTEIN IIB/IIIA RECEPTORS IN CARDIOVASCULAR MEDICINE [J].
LEFKOVITS, J ;
PLOW, EF ;
TOPOL, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) :1553-1559
[18]   PERSISTENT ACTIVATION OF COAGULATION MECHANISM IN UNSTABLE ANGINA AND MYOCARDIAL-INFARCTION [J].
MERLINI, PA ;
BAUER, KA ;
OLTRONA, L ;
ARDISSINO, D ;
CATTANEO, M ;
BELLI, C ;
MANNUCCI, PM ;
ROSENBERG, RD .
CIRCULATION, 1994, 90 (01) :61-68
[19]   ANGIOSCOPIC EVALUATION OF CORONARY-ARTERY THROMBI IN ACUTE CORONARY SYNDROMES [J].
MIZUNO, K ;
SATOMURA, K ;
MIYAMOTO, A ;
ARAKAWA, K ;
SHIBUYA, T ;
ARAI, T ;
KURITA, A ;
NAKAMURA, H ;
AMBROSE, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (05) :287-291
[20]   Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men [J].
Muller, TH ;
Weisenberger, H ;
Brickl, R ;
Narjes, H ;
Himmelsbach, F ;
Krause, J .
CIRCULATION, 1997, 96 (04) :1130-1138
123